IM Cannabis Corp.

NASDAQ: IMCC · Real-Time Price · USD
2.71
0.05 (1.88%)
At close: Aug 15, 2025, 12:13 PM

IM Cannabis Income Statement

Financials in CAD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
54.47M 54.03M 51.39M 49.88M 48.34M 49.45M 53.21M 55.01M 65.63M 65.45M 71.02M 64.89M 52.18M 47.95M 32.82M 30.67M 23.32M
Cost of Revenue
44.35M 45.58M 44.78M 43.77M 39.62M 38.96M 40.96M 43.45M 44.2M 45.17M 49.03M 44.93M 46.11M 39.25M 27.93M 22.32M 12.41M
Gross Profit
10.12M 8.45M 6.61M 6.11M 8.72M 10.49M 12.25M 11.56M 12.12M 10.98M 12.68M 10.66M 6.07M 8.7M 4.89M 8.35M 10.9M
Operating Income
-15.71M -21.49M -6.97M -10.19M -11.3M -4.57M -10.11M -13.38M -20.75M -13M -14.01M -16.61M -21.7M -32.27M -26.93M -19.48M -11.61M
Interest Income
n/a n/a 58K 927K 927K 4.46M 7.32M 7.65M 10.88M 10.24M 7.72M 15.14M 18.13M 22.46M 22.05M 14.62M 8.62M
Pretax Income
-6.52M -12.79M -14.23M -15.14M -14.71M -9.46M -16.52M -18.84M -19.68M -26.1M -28.5M -23.68M -24.02M -11.5M -19.97M -19.95M -24.64M
Net Income
-4.69M -10.59M -12.86M -14.08M -14.51M -9.75M -39.49M -165.49M -181M -189.59M -169.46M -45.61M -31.72M -17.76M -24.23M -19.29M -23.78M
Selling & General & Admin
11.91M 13.28M 15.51M 16.31M 17.45M 19.03M 29.33M 31.9M 34.22M 35.5M 38.23M 38.8M 41.75M 40.97M 31.81M 27.82M 22.41M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 4K 9K 10K 11K 8K 110K
Other Expenses
13.91M 16.67M -1.92M -15K 5.74M -3.96M -6.95M -6.95M -6.32M -13.34M -13.35M -13.35M -13.99M -14K -4K n/a n/a
Operating Expenses
25.83M 29.95M 13.59M 16.29M 23.19M 15.07M 22.38M 24.95M 27.9M 22.16M 24.88M 25.45M 27.78M 40.96M 31.82M 27.82M 22.52M
Interest Expense
1.44M 1.93M 1.93M 1.93M 2.62M 2.91M 2.91M 2.91M 2.99M 3.53M 4.37M 4.37M 2.72M 1.69M 14.95M 14.95M 21.49M
Selling & Marketing Expenses
955K 1.97M 43K 1.1M 2.24M 2.75M 11.09M 11.32M 11.82M 11.47M 12.72M 11.63M 9.81M 8.54M 5.65M 5.09M 4.49M
Cost & Expenses
70.17M 75.53M 58.37M 60.07M 59.64M 50.86M 60.17M 65.23M 72.11M 67.33M 73.91M 70.38M 73.88M 80.22M 59.75M 50.15M 34.93M
Income Tax Expense
-941K -1.02M -155K -4K 675K 770K -160K -81K -928K -1.14M -698K -1.24M -192K 536K -453K -342K -416K
Shares Outstanding (Basic)
3.08M 2.35M 2.23M 2.19M 2.23M 2.14M 2.14M 2.22M 1.81M 2.46M 2.46M 2.46M 3.11M 3.11M 3.11M 5.09M 4.09M
Shares Outstanding (Diluted)
3.08M 2.35M 2.23M 2.19M 2.23M 2.14M 2.14M 2.22M 1.81M 1.21M 4.42M 7.03M 6.75M 6.75M 5.92M 5.09M 4.09M
EPS (Basic)
-2.13 -4.74 -5.78 -6.33 -6.51 -4.31 -16.27 -67.41 -73.57 -76.29 -67.01 -16.29 -9.57 -5.43 -5.93 -4.38 -5.93
EPS (Diluted)
-2.13 -4.74 -5.79 -6.34 -6.52 -4.32 -10.31 -38.35 -39.49 -40.57 -35.01 -6.73 -5.03 -2.53 -5 -4.1 -5.68
EBITDA
-3.36M -8.9M -5.87M -6.95M -5.18M 456K -8.43M -20.73M -20.38M -25.24M -27.51M -19.78M -22.74M -12.7M -9.78M -2.86M -1.93M
EBIT
-5.29M -11.08M -8.25M -9.55M -8.08M -2.54M -12.15M -15.42M -16.51M -22.4M -25.33M -27.92M -29.92M -18.43M -13.64M -5.01M -3.15M
Depreciation & Amortization
1.93M 2.18M 2.37M 2.6M 2.9M 3M 3.73M 4.86M 6.3M 7.33M 7.99M 8.15M 7.18M 5.73M 3.86M 2.15M 1.22M